Bullish indicating open at $55-$60, IPO prices at $37
Investing.com -- VSee Health Inc. (OTC:VSEE) stock plunged 53% after the company announced it received a delisting notice from Nasdaq, with trading suspension scheduled for August 14.
The healthcare technology company disclosed that Nasdaq’s Listing Qualifications Department has denied its request to maintain its listing status due to non-compliance with filing requirements. VSee failed to timely file both its annual report for the fiscal year ended December 31, 2024, and its quarterly report for the period ended March 31, 2025.
Following the suspension, VSee’s common stock and warrants will transition to trading on the OTC Markets system under the same symbols "VSEE" and "VSEEW," respectively. The company plans to appeal the determination to the Nasdaq Listing and Hearing Review Council, though there is no guarantee the appeal will be successful.
The delisting process will be completed when Nasdaq files a Notification of Removal from Listing and/or Registration on Form 25 with the SEC after applicable appeal periods expire. The company warned investors that the move to OTC Markets could result in significantly reduced liquidity and trading volume.
VSee cautioned shareholders that once delisted, "there may be a very limited market in which the Company’s common stock and warrants are traded," making it potentially "difficult to sell their shares" and likely adversely affecting trading prices.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.